Revenue segments as reported by the company.

Smokeable Products

Oral Tobacco Products

Wine

All Other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Marketing, administration and research costs

Asset impairment and exit costs

Amortization of intangibles

General corporate expenses

Corporate asset impairment and exit costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Altria

Altria Group, Inc. operates as a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral tobacco products, and Wine. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral tobacco products segment is primarily moist smokeless tobacco products (MSTs) through brands like Copenhagen and Skoal as well as on! oral nicotine pouches sold by Helix. The Wine segment, through subsidiary Ste. Michelle Wine Estates Ltd, produces Washington State wines, primarily Chateau Ste. Michelle and 14 Hands, and owns wineries in or distributes wines from several other wine regions. The company was founded in 1919 and is headquartered in Richmond, VA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Altria reports robust Q4 earnings, focuses on innovation and growth

Altria's Q4 2022 performance reflects resilience amidst industry challenges, with a focus on innovation and shareholder returns. The company's strategic initiatives in smoke-free products and digital engagement underscore its commitment to long-term growth and harm reduction.

Altria reports resilient Q1 performance amid industry challenges and opportunities

Altria's Q1 2023 earnings call highlighted strong performance amidst industry challenges, emphasizing harm reduction and regulatory compliance. The company faces hurdles from inflation, regulatory changes, and evolving consumer behaviors, while focusing on growth opportunities in smoke-free products and strategic investments.

Altria reports solid Q2 earnings, eyes e-vapor growth opportunities

Altria's focus on smoke-free products and NJOY acquisition driving growth.
Challenges in the cigarette industry due to economic pressures and flavor bans.
Opportunities in the e-vapor category and expansion plans in the U.S.
Strong balance sheet and significant capital returns to shareholders.

Altria reports growth in earnings, navigates regulatory challenges in e-vapor

Altria's Q3 2023 earnings call highlighted solid financial performance, strategic focus on e-vapor products, and efforts to combat illegal vape products. The company faces challenges from regulatory uncertainties and illicit products but sees opportunities in expanding NJOY's reach and addressing market gaps.

Altria reports growth in smoke-free products amidst regulatory challenges

Altria's Q4 2023 earnings call highlighted growth in adjusted EPS, strategic focus on smoke-free products, and efforts to combat illicit e-vapor products. The company faces challenges in competitive segments and economic pressures but sees opportunities in new product introductions and regulatory collaborations.

Altria reports mixed Q1 performance, focuses on growth strategies

Altria's Q1 performance showed growth in NJOY and oral tobacco segments, with challenges in EPS decline and economic pressures on consumers.
Strengths include reaffirmed EPS guidance, strategic investments, and focus on combating illicit e-vapor products.
Opportunities lie in maximizing profitability in oral tobacco, product positioning, and capturing transitioning consumers.
Overall, Altria's performance reflects a mix of growth, challenges, and strategic opportunities in navigating market dynamics.

Altria's NJOY drives growth as company navigates e-vapor challenges

Altria's Q2 2024 earnings call showcased strong performance in smoke-free products, highlighting growth in retail share and volume momentum. Despite challenges in the e-vapor category, the company remains focused on responsible regulation and enforcement. With a commitment to shareholder value and long-term growth strategies, Altria is poised for continued success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Altria Group, Inc. is a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral Tobacco Products, and All Other. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral Tobacco Products segment includes MST and snus products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix. The All Other segment refers to the financial results of NJOY, Helix ROW, and the IQOS System heated tobacco business. The company was founded in 1919 and is headquartered in Richmond, VA.

Altria is selling $2.4 billion worth of its stock in AB/InBev. It plans to use that cash to buy back stock.

Altria Has a New Plan to Unlock Value. It Could Be a Warning Sign for the High-Yield Dividend Stock.

Hess Midstream Partners

National Retail Properties

Philip Morris

Every month, we look at companies that are delivering not only a solid dividend yield but also showing a trend of growing dividends. One of my main goals for investing is to generate my own growing cash flows passively over time through dividend payers. The dividend stocks that showed up in the screening that we'll be touching on today include Altria, Hess Midstream, 3M, Philip Morris, and NNN REIT.

March's 5 Dividend Growth Stocks With 5.48%+ Yields

Amazon

British American Tobacco

Pacer US Cash Cows 100 ETF

Enbridge

Enterprise Products Partners

iShares Russell Top 200 Growth ETF

KFA Mount Lucas Index Strategy ETF

Lear

MPLX

Netflix

ServiceNow

NVIDIA

Schwab US Dividend Equity ETF

Invesco S&P 500 GARP ETF

PIMCO 25+ Year Zero Coupon US Treasury Index ETF

Building the right portfolio for your needs is essential to achieving your goals. With a great portfolio strategy, you can become confident in achieving your dreams. This article highlights the ZEUS portfolio strategy, which focuses on a time-tested, recession-optimized asset allocation that delivers the best total returns per unit of negative volatility. 33% ETFs, 33% hedges, and 33% individual stocks enhance a diversified and balanced mix of growth, yield, and value and are wrapped within the highest quality company wrappers.

Building A 4% Yielding Sleep Well At Night Retirement Portfolio With 16 Blue-Chip Stocks And ETFs

Altria (MO) closed the most recent trading day at $43.87, moving -0.93% from the previous trading session.

Why Altria (MO) Dipped More Than Broader Market Today

Archer-Daniels-Midland Company

Black Hills

Federal Realty Investment Trust

Fortis

Hormel Foods

Kenvue

Leggett & Platt

Middlesex Water

National Fuel Gas

Northwest Natural Gas

PepsiCo

SJW Group

United Bankshares

Universal Corp

A Dividend King is a stock with 50 or more consecutive years of dividend increases. The 55 Dividend Kings screened as of March 13 represented 9 of 11 Morningstar Sectors. Broker targeted-top-ten net gains ranged 14.63%-22.93% topped by Middlesex Water, and SJW Group. By yield, Leggett tops-all. Top-ten March Kings; UBSI, FRT, FTS, BKH, NWN, MMM, CDUAF, UVV, MO, & LEG averaged 5.97% yield.

55 March Dividend Kings: Buy 8; Watch 4

Altria (MO) divests 35 million shares of Anheuser-Busch InBev. Management expands share repurchase plans while raising the bottom-line view for 2024.

Altria (MO) Ups Earnings View, Expands Share Buyback Plans

Anheuser-Busch InBev

Anheuser-Busch InBev (BUD) saw its American Depositary Receipts (ADRs) fall by over 5% on Thursday. The downturn followed the announcement from Altria (MO) that it would reduce its 10% stake in the world's largest brewer through a secondary offering at a discounted price, triggering market reactions and investor speculation.

Altria cuts stake in AB InBev, shares dip amid secondary offering

Shares of AB InBev, the world's biggest brewer, slipped more than 4% Thursday as trading resumed following a brief suspension.

Budweiser-owner AB InBev slides 4% after trading suspension as Altria sells stake

Altria late Wednesday said it plans to sell part of its stake in Anheuser-Busch InBev, which it will use to buy back its own stock.

Marlboro maker to sell $2.3 billion worth of Bud Light maker's stock

RICHMOND, Va.--(BUSINESS WIRE)---- $MO #Altria--Altria to Significantly Enhance Cash Return to Shareholders Through Expanded Share Repurchase Program in Connection with Pricing Program.

Altria to Significantly Enhance Cash Returns to Shareholders Through Expanded Share Repurchase Program in Connection with Pricing of Offering of Anheuser-Busch InBev Stock; Raises 2024 Full-Year Earnings Guidance

Altria (MO) reveals intentions to divest a portion of its stake in Anheuser-Busch InBev SA/NA via a global secondary offering.

Altria (MO) Plans to Sell Partial Stake in Anheuser-Busch InBev

Anheuser-Busch (NYSE: BUD ) stock is in the news Thursday as investors react to news of tobacco company Altria (NYSE: MO ) selling a portion of its stake in the beer manufacturer. Altria has announced that it will be selling 35 million shares of BUD stock.

Is Altria Giving Up on Anheuser-Busch (BUD) Stock?

Robinhood revolutionized commission free investing, and it continues to do so today.

Could Altria Stock Be Better Than Universal Corporation in 2024?

Pfizer

Stock investors who want to receive $2,000 per month in dividend payments first have to do some quick math. A dividend portfolio with stocks valued at $480,000 yielding 5% overall would produce $24,000 in annual dividends.

Want $2K Per Month in Retirement? Buy These 3 Dividend Stocks Now.

Marlboro cigarettes owner Altria Group Inc (NYSE:MO, ETR:PHM7) has unveiled plans to sell a US$2.2 billion stake in Budweiser brewer Anheuser-Busch InBev (NYSE:BUD) SA. Dubbing the transaction “opportunistic”, Altria said 35 million shares in the brewing giant would be sold to fund its own future buybacks.

Marlboro maker sells $2.2bn stake in Budweiser owner

Alliance Resource Partners

Companies that pay a regular dividend have crushed non-payers in the return department over the last half-century. Though they're not everyone's cup of tea, vice stocks -- businesses in industries some investors might view as immoral or undesirable -- are known for their juicy dividends.

Want $600 in Super Safe Annual Dividend Income? Invest $5,925 Into the Following 3 Ultra-High-Yield "Vice" Stocks.

Altria Group plans to sell 18%, or over $2 billion worth, of its large stake in Anheuser-Busch InBev in a secondary offering as it looks to return more cash to shareholders.

Altria Group Plans to Sell Part of Anheuser-Busch Stake

RICHMOND, Va.--(BUSINESS WIRE)---- $MO #ALTRIA--ALTRIA ANNOUNCES INTENT TO SELL A PORTION OF ITS INVESTMENT IN ANHEUSER-BUSCH INBEV.

Altria Announces Intent to Sell a Portion of its Investment in Anheuser-Busch InBev

Altria Group stock has slightly trailed the S&P 500 but remained resilient. MO attracts investors with its cheap valuation and robust dividend yields. Altria faces a structural decline in its legacy tobacco portfolio and must improve its portfolio transition to sustain a valuation re-rating. Despite challenges, Altria management is confident in its 2024 outlook and sees more robust growth in the second half of the year.

Altria: High-Yield Income Play Still Too Cheap To Ignore

Accenture Plc

Aflac

Ameriprise Financial

Amphenol

Broadcom

Blackrock Inc

Caterpillar

Cummins

Fastenal

Hershey

Illinois Tool Works

Kroger

New Linde PLC

Lowe's

Mastercard

Medtronic

McCormick

Microsoft

Paychex

Packaging Corp of America

Starbucks

Tractor Supply

Dividend growth investors focus on consistently growing dividends rather than high yields, as it ensures income continues to grow over time. Dividend safety is often considered of utmost importance for an income investor; however, future dividend growth can pose a greater risk to meeting future goals. The dividend growth coverage ratio, which compares earnings growth to dividend growth, can help determine a company's ability to sustain dividend growth in the long run.

Rethinking Risk: Why It's Time To Shift Focus From Dividend Safety To Dividend Growth

News for Altria Stock (MO)